Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Stereotactic Radiosurgery
How would you manage intracranial extramedullary hematopoiesis?
Dose/fractionation?
Related Questions
How do you use Boswellia for radiation necrosis?
If memantine were started 6 weeks after completion of radiation to base of skull, would you expect any potential benefit?
How do you draw your treatment volumes when treating meningiomas with fractionated SRS?
Would you manage a subtotally resected pilocytic astrocytoma with deleted CDKN2A differently than one with intact CDKN2A?
Have you used radiation to treat systemic therapy resistant, problematic lesion of granulomatosis with polyangitis?
How would you treat grade 3 cauda equina meningioma status post biopsy only with a history of prior prostate/whole pelvis radiation?
What dose, constraints, and technical parameters would you use for a SIB FSRT plan for a large brain metastasis resection cavity with rapid interval tumor growth along periphery of the resection cavity?
How do you proceed with radiation planning for preliminary suspected high grade gliomas after surgery when there is a delay in final molecular diagnosis?
Do you treat an arteriovenous fistula with the same principles as an arteriovenous malformation?
How would you manage a patient with a symptomatic mature intracranial teratoma who is a not a surgical candidate?